Cell lines used in this study include standard human T cell leukemia (Jurkat), human B cell leukemia (NALM6) cell lines, and a patient-derived B cell leukemia cell line that we have previously reported [658w, (21)]. All cell lines were cultured in RPMI 1640 medium (catalog no. R0883; Sigma-Aldrich) supplemented with 10% fetal bovine serum (Sigma-Aldrich), 0.5% l-glutamine (BioConcept), and 0.5% penicillin/streptomycin (Life Technologies) and incubated at 37° until colonies reached a population size of about 5 × 105 cells/ml. Cells were passaged every 3 days by dilution of the cells to a concentration of around 1 × 105 cells/ml.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.